The role of duloxetine in the treatment of anxiety disorders

QR Code

The role of duloxetine in the treatment of anxiety disorders

Domenico De Berardis1,2,3, Nicola Serroni2, Alessandro Carano1,4, Marco Scali1,4, Alessandro Valchera5, Daniela Campanella1,2, Alessandro D&rsquo;Albenzio1, Berardo Di Giuseppe2, Francesco Saverio Moschetta2, Rosa Maria Salerno1, Filippo Maria Ferro11Department of Oncology and Neurosciences,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Domenico De Berardis, Nicola Serroni, Alessandro Carano, Marco Scali, Alessandro Valchera, et al
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/a5df458efc8343dda82baca21994ae6f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Duloxetine in the treatment of generalized anxiety disorder
par: Trevor R Norman, et autres
Publié: (2009)

Duloxetine for the treatment of generalized anxiety disorder: a review
par: Ahsan Y Khan, et autres
Publié: (2008)

Duloxetine in panic disorder with somatic gastric pain
par: Preve M, et autres
Publié: (2013)

Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
par: Michele Fornaro, et autres
Publié: (2011)

Evidence to practice: treatment of anxiety in individuals with autism spectrum disorders
par: Russell Lang, et autres
Publié: (2011)

New treatment options for fibromyalgia: critical appraisal of duloxetine
par: Nurcan &Uuml;&ccedil;eyler, et autres
Publié: (2008)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
par: Bernhard T Baune
Publié: (2008)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
par: Maneeton B, et autres
Publié: (2018)

Pregabalin for the treatment of generalized anxiety disorder: an update
par: Baldwin DS, et autres
Publié: (2013)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
par: Harada E, et autres
Publié: (2015)

Role of paliperidone extended-release in treatment of schizoaffective disorder
par: Carla M Canuso, et autres
Publié: (2010)

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
par: Prasko J, et autres
Publié: (2016)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
par: Harada E, et autres
Publié: (2016)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
par: Levitan MN, et autres
Publié: (2015)

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review
par: Fornaro M, et autres
Publié: (2016)

Differential attentional bias in generalized anxiety disorder and panic disorder
par: Chen J, et autres
Publié: (2013)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
par: Haider M, et autres
Publié: (2017)

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
par: Nagao K, et autres
Publié: (2013)

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
par: Atake K, et autres
Publié: (2015)

Epilepsy and suicide: pathogenesis, risk factors, and prevention
par: Alberto Verrotti, et autres
Publié: (2008)

The Potential Role of Epigenetic Drugs in the Treatment of Anxiety Disorders
par: Peedicayil J
Publié: (2020)

Anxiety disorders and GABA neurotransmission: a disturbance of modulation
par: Nuss P
Publié: (2015)

A review of neuroimaging studies of anxiety disorders in China
par: Chen J, et autres
Publié: (2011)

Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment
par: G&eacute;rard A, et autres
Publié: (2012)

Social anxiety disorder: A review of environmental risk factors
par: Christina A Brook, et autres
Publié: (2008)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
par: Huang J, et autres
Publié: (2018)

Imitation and communication skills development in children with pervasive developmental disorders
par: Andrea De Giacomo, et autres
Publié: (2009)

Transcranial magnetic stimulation for the treatment of anxiety disorder
par: Rodrigues PA, et autres
Publié: (2019)

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
par: Zou C, et autres
Publié: (2013)

Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities
par: Ociskova M, et autres
Publié: (2015)

Movement Disorders Associated with COVID-19
par: Mehri Salari, et autres
Publié: (2021)

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
par: Kuga A, et autres
Publié: (2017)

SAFA: A new measure to evaluate psychiatric symptoms detected in a sample of children and adolescents affected by eating disorders. Correlations with risk factors
par: Emilo Franzoni, et autres
Publié: (2009)

Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder
par: Tian-Xiang Zhang, et autres
Publié: (2021)

Examining the effect of a wearable, anxiety detection technology on improving the awareness of anxiety signs in autism spectrum disorder: a pilot randomized controlled trial
par: Jenny Nguyen, et autres
Publié: (2021)

Cognitive impairment in generalized anxiety disorder revealed by event-related potential N270
par: Yang Y, et autres
Publié: (2015)

The role of paliperidone extended release for the treatment of bipolar disorder
par: Marino J, et autres
Publié: (2012)

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study
par: Fontani V, et autres
Publié: (2011)

Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
par: Ariadna Laguna, et autres
Publié: (2021)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
par: Jean-Michel Azorin, et autres
Publié: (2010)